Immunomodulators - Part A

1. Marine-Derived Polysaccharides and Peptides as Next-Generation Immunomodulators: Molecular Mechanisms, Therapeutic Potential, and Translational Challenges<br>2. Advances in Immunomodulation: From Dietary Influence to Computational Precision<br>3. iPSC-derived immunotherapy for Tau and Alzheimer's disease<br>4. Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's Disease<br>5. Biosimilars: Antibody and Nanobody Based Therapeutic Approaches Towards Protein Misfolding Diseases<br>6. Immunomodulator drugs: mechanisms of action and systemic effects<br>7. Microbiome and microbial products as immunomodulators: implication for gastrointestinal cancers<br>8. Integration of Network pharmacology, docking, and dynamics analysis to investigate the immunomodulatory activity of Pongamia pinnata<br>9. Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A bioinformatics Approach<br>10. Utilizing DREIMT Database for Drug Prioritization in Immunomodulatory Therapy for Psoriasis and Psoriatic Arthritis<br>11. Targeting Immune Modulation Genes in Mpox. A Therapeutic Approach Using Natural Compounds<br>12. Identification of Common Hub Genes and Pathways in Systemic Lupus Erythematosus and Cervical Cancer Using Bioinformatics Approach<br>13. Transcriptomic Profiling Reveals Immune Pathway Dysregulation and Key Interferon-Responsive Genes in Systemic Lupus Erythematosus<br>14. TBC*<br>15. TBC*<br>16. Synthetic Immunomodulators: Revolutionizing Immunotherapy<br>17. Therapeutics Immunotargets for Tauopathy<br>18. Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer's disease<br>19. VISTA as a double-edged immune checkpoint molecule in cancer and autoimmunity